188 related articles for article (PubMed ID: 36219797)
21. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
van Vliet EA; Edelbroek PM; Gorter JA
Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
[TBL] [Abstract][Full Text] [Related]
22. Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study.
Milano C; Turco F; Pizzanelli C; Bonanni E; Siciliano G; Fornai F; Giorgi FS
Epilepsy Behav; 2021 Feb; 115():107706. PubMed ID: 33423017
[TBL] [Abstract][Full Text] [Related]
23. Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial.
Tabrizi N; Zarvani A; Rezaei P; Cheraghmakani H; Alizadeh-Navaei R
Epilepsy Res; 2019 Nov; 157():106214. PubMed ID: 31627041
[TBL] [Abstract][Full Text] [Related]
24. The Relationship Between Valproate and Lamotrigine/Levetiracetam Use and Prognosis in Patients With Epilepsy and Heart Failure: A Danish Register-Based Study.
Liang D; Gardella E; Kragholm K; Polcwiartek C; Sessa M
J Card Fail; 2022 Apr; 28(4):630-638. PubMed ID: 34438055
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of anti-epileptic drugs-an internet study.
Wieshmann UC; Baker G
Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951
[TBL] [Abstract][Full Text] [Related]
26. A Multicenter Study of Self-Limited Epilepsy With Centrotemporal Spikes: Effectiveness of Antiseizure Medication With Respect to Spike-Wave Index.
Dilber B; Serdaroğlu E; Kanmaz S; Kılıç B; İpek R; Menderes DK; Yıldız N; Topçu Y; Arhan EP; Serdaroğlu A; Okuyaz Ç; Aydın K; Tekgül H; Cansu A
Pediatr Neurol; 2024 Mar; 152():79-86. PubMed ID: 38237317
[TBL] [Abstract][Full Text] [Related]
27. Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy.
Chonan M; Saito R; Kanamori M; Osawa SI; Watanabe M; Suzuki H; Nakasato N; Tominaga T
Neurol Med Chir (Tokyo); 2020 Jan; 60(1):37-44. PubMed ID: 31748440
[TBL] [Abstract][Full Text] [Related]
28. Effects of valproate, lamotrigine, and levetiracetam monotherapy on bone health in newly diagnosed adult patients with epilepsy.
Guo Y; Lin Z; Huang Y; Yu L
Epilepsy Behav; 2020 Dec; 113():107489. PubMed ID: 33220583
[TBL] [Abstract][Full Text] [Related]
29. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW
J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651
[TBL] [Abstract][Full Text] [Related]
30. Levetiracetam versus Phenobarbital for Neonatal Seizures: A Retrospective Cohort Study.
Bättig L; Dünner C; Cserpan D; Rüegger A; Hagmann C; Schmitt B; Pisani F; Ramantani G
Pediatr Neurol; 2023 Jan; 138():62-70. PubMed ID: 36401982
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
Ben-Menachem E; Falter U
Epilepsia; 2000 Oct; 41(10):1276-83. PubMed ID: 11051122
[TBL] [Abstract][Full Text] [Related]
32. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).
Stepanova D; Beran RG
Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809
[TBL] [Abstract][Full Text] [Related]
33. Levetiracetam as first-line monotherapy for Idiopathic Generalized Epilepsy in women.
Ballvé A; Salas-Puig J; Quintana M; Campos D; Llauradó A; Raspall M; Fonseca E; Abraira L; Santamarina E; Toledo M
Acta Neurol Scand; 2021 Apr; 143(4):407-412. PubMed ID: 33452703
[TBL] [Abstract][Full Text] [Related]
34. Trends in Antiseizure Medication Initiation, Switch, or Termination in Patients With Newly Diagnosed Epilepsy: A Nationwide Study.
Bolin K; Patric B; Tomson T
Neurology; 2024 Jul; 103(2):e209500. PubMed ID: 38870473
[TBL] [Abstract][Full Text] [Related]
35. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
Mink S; Muroi C; Seule M; Bjeljac M; Keller E
Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of monotherapy versus duotherapy antiseizure drug management for postoperative seizure control in patients undergoing an awake craniotomy.
Eseonu CI; Eguia F; Garcia O; Kaplan PW; Quiñones-Hinojosa A
J Neurosurg; 2018 Jun; 128(6):1661-1667. PubMed ID: 28621631
[TBL] [Abstract][Full Text] [Related]
37. Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study.
van der Meer PB; Dirven L; Fiocco M; Vos MJ; Kerkhof M; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
J Neurooncol; 2023 Sep; 164(3):545-555. PubMed ID: 37755633
[TBL] [Abstract][Full Text] [Related]
38. Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy.
Cerulli Irelli E; Cocchi E; Morano A; Gesche J; Caraballo RH; Lattanzi S; Strigaro G; Catania C; Ferlazzo E; Pascarella A; Casciato S; Quarato P; Pizzanelli C; Pulitano P; Giuliano L; Viola V; Mostacci B; Fortunato F; Marini C; Di Gennaro G; Gambardella A; Labate A; Operto FF; Giallonardo AT; Baykan B; Beier CP; Di Bonaventura C;
JAMA Neurol; 2023 Nov; 80(11):1174-1181. PubMed ID: 37782485
[TBL] [Abstract][Full Text] [Related]
39. Valproate but not levetiracetam slows the EEG alpha peak frequency - A pharmaco-EEG study.
Zöllner JP; Strzelczyk A; Rosenow F; Kienitz R
Clin Neurophysiol; 2021 Jun; 132(6):1203-1208. PubMed ID: 33875373
[TBL] [Abstract][Full Text] [Related]
40. Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
Happold C; Gorlia T; Chinot O; Gilbert MR; Nabors LB; Wick W; Pugh SL; Hegi M; Cloughesy T; Roth P; Reardon DA; Perry JR; Mehta MP; Stupp R; Weller M
J Clin Oncol; 2016 Mar; 34(7):731-9. PubMed ID: 26786929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
